Announcements Trials
Browse Landscape

Phase

Phase 4 6Phase 3 6Phase 2 4Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1

Status

Completed 21Unknown 9Active not recruiting 8Recruiting 7Terminated 6Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1Genitourinary 1Classical hematology 1Breast 1

Conditions

Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neoplasms 1Metabolic Diseases 1Leukemia, Myeloid, Acute 1Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1Anemia, Aplastic 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Saline Solution × Clear all
NCT03085004 2026-03-30

CHARM

Milton S. Hershey Medical Center

Phase 3 Terminated
75 enrolled
Gastrointestinal

Pancreatic Cyst

NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Sun Yat-sen University

Phase 3 Terminated
76 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Terminated
81 enrolled 19 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04571645 2024-04-15

AML

Jazz Pharmaceuticals

Phase 3 Terminated
9 enrolled 9 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01956812 2021-08-16

PANCRIT®-1

Gilead Sciences

Phase 3 Terminated
334 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01343680 2012-05-30

Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients

Alberta Children's Hospital

Phase 3 Terminated
2 enrolled
Classical hematology

Anemia, Aplastic, Metabolic Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡